by The global Peptide Therapeutics Market is estimated to be valued at US$ 44,386.9 Mn or Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Peptide therapeutics are peptide-based drugs used for treating various diseases. They have advantages over non-peptide drugs as they exhibit high selectivity and affinity to target receptors. Peptides can be used for conditions where conventional drugs may have issues related to toxicity, stability or resistance.
Market key trends:
One of the key trends in the peptide therapeutics market is increasing investment in research and development of peptides for chronic and complex diseases. Peptides have potential to treat conditions for which current therapies are inadequate. Several biotech and pharmaceutical companies are conducting clinical trials to evaluate efficacy and safety of peptide drug candidates for diseases like cancer, metabolic disorders, neurological conditions etc. This is expected to drive the market growth during the forecast period.
Market key trends:
One of the key trends in the peptide therapeutics market is the increasing use of peptides to discover drug targets and develop new therapeutic agents. Peptides have superior properties like higher selectivity and affinity, favorable safety profiles, and more specific receptor interactions. This makes them ideal candidates for drug discovery and development. Various peptide-based drugs and therapeutics are in the pipeline for conditions like cancer, metabolic disorders, cardiovascular disease, and more.
SWOT Analysis
Strength: High selectivity and affinity for target receptors, favorable safety profiles, specific receptor interactions.
Weakness: Low oral bioavailability, stability issues requiring alternative routes of administration.
Opportunity: Large pipeline of peptide drugs and therapeutics for cancer, metabolic disorders, cardiovascular disease etc.
Threats: High development costs, manufacturing challenges of large-scale production.
Key Takeaways
The Global Peptide Therapeutics Market Size was valued at US$ 44,386.9 million in 2023. The market is expected to witness high growth, exhibiting a CAGR of 6.6% over the forecast period, due to increasing R&D investments in peptide drug discovery and biologics development.
North America accounted for the largest share of the global peptide therapeutics market in 2023 due to presence of major players, growing biologics market, rising healthcare spending, and increasing prevalence of chronic diseases in the region.
Key players operating in the peptide therapeutics market are Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
